AC Immune (ACIU) Long-Term Investments (2016 - 2017)
AC Immune's (ACIU) quarterly Long-Term Investments came in at $93379.9 in Q2 2017, up 202.01% year-on-year from $30919.1 in Q2 2016, and up 434.85% on a QoQ basis from -$27887.0 in Q1 2017.
AC Immune (ACIU) Long-Term Investments (2016 - 2017) Analysis & Trends
AC Immune (ACIU) has 2 years of Long-Term Investments data on file, last reported at $93379.9 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 93,379.88 |
| Mar 31, 2017 | -27,886.98 |
| Jun 30, 2016 | 30,919.14 |
| Mar 31, 2016 | 29,200.61 |